Breast cancer (BC) consists of multiple subtypes defined by various molecular
characteristics, for instance, estrogen receptor (ER) expression. Methods for visualizing BC …

A growing body of evidence suggests that gastrin-releasing peptide receptor (GRPR) might
be a valuable target in breast cancer. To understand which patients can be potential …

This study reports on the uptake of 99mTc-RP527 by human breast carcinoma and its
relationship to gastrin-releasing peptide receptor (GRP-R) expression as measured by …

Introduction: The gastrin-releasing peptide receptor (GRPR) is overexpressed in breast
cancer. The present study evaluates GRPR imaging as a novel imaging modality in breast …

Background Overexpression of the gastrin-releasing peptide receptor (GRP-R) has been
documented in several human neoplasms such as breast, prostate, and ovarian cancer …

Background The gastrin-releasing peptide receptor (GRP-R) is expressed in several normal
human tissues and is overexpressed in various human tumors including breast, prostate …

The Gastrin-Releasing Peptide Receptor (GRPR) is over-expressed in estrogen receptor
(ER) positive breast tumors and related metastatic lymph nodes offering the opportunity of …

Imaging and therapy using radioligands targeting receptors overexpressed on tumor cells is
successfully applied in neuroendocrine tumor patients. Because expression of the gastrin …

Gastrin-releasing peptide (GRP) has been shown to be a tumour growth stimulating agent
for a number of normal and human cancer cell lines. The tumour growth effect is a direct …

Gastrin-releasing peptide receptors (GRP-R) are upregulated in many cancers, including
prostate, breast, and lung. We describe a new radiolabeled bombesin (BBN) analog for …